Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Supplementary Appendix
创建时间：
2020-09-24
